Xilis believes cultivating micro-tumors may hold the key to more effective cancer treatments

Despite near-miraculous advances in the treatment of cancer in the U.S. and around the world, the disease remains the second leading cause of death in America. The problem is that every manifestation of the disease is unique to the patient that is afflicted by it, because everyone’s body is actually different. Most cancer treatments are determined by their ability to cure the largest population afflicted with a particular cancer type. As understanding of the disease has advanced, more targeted treatments are coming to market to treat particular types of the disease. And now, Xilis has developed a process that its founders hope will make those treatments even more effective. Founded by Xiling Shen and Dr. David Hsu, two Duke University …

Trialjectory uses self-reported clinical data to match cancer patients with clinical trials

“As cancer is the second leading cause of death for Americans – with thousands of new cases diagnosed each year – having access to advanced treatment options is a necessity, not a privilege, as new trials provide better outcomes to patients,” said Tzvia Bader, TrialJectory chief executive and co-founder. “What’s more, one of the top obstacles that oncologists face today is the lack of clinical trial access for patients, which is due to the availability of more treatment options overall. Additionally, it is a very complex process to match the right patient with the right treatment, especially with the rise of personalized medicine.” “TrialJectory’s work – driven by a highly experienced management team, comprised of both oncology and technology experts – is disrupting …

Zantac in global recall over ‘unacceptable’ levels of potential carcinogen

Heartburn medicine pulled by GlaxoSmithKline while it investigates source of impurity GlaxoSmithKline is recalling the popular heartburn medicine Zantac in all markets, days after the US Food and Drug Administration (FDA) found unacceptable levels of probable cancer-causing impurity in the drug. Zantac, also sold generically as ranitidine, is the latest drug in which cancer-causing impurities have been found. Regulators have been recalling some blood pressure and heart failure medicines since last year. Britains medicines watchdog said GlaxoSmithKline (GSK) was recalling four prescription-only Zantac medicines a syrup, an injection and tablets of 150mg and 300mg dosages over an potential carcinogen called N-nitrosodimethylamine (NDMA) Over-the-counter 75mg dosage Zantac products are produced by a different company and are not affected by the recall, …

Uproar after research claims red meat poses no health risk

One expert says findings by international experts represent egregious abuse of evidence New research that claims red and processed meat is probably not harmful to our health has caused controversy among experts who maintain people should cut down. The World Health Organization has classified red and processed meats as cancer-causing. Public health bodies worldwide urge people to limit their intake of red and processed meat to reduce their cancer risk. The NHS advises that people who eat 90g of meat a day equivalent to three thin slices of roast meat should cut down to 70g. Aside from public health, calls are multiplying for people to cut back on meat consumption because of the climate emergency and the greenhouse gas emissions …